Light induced drug delivery into cancer cells

Biomaterials

Volumn 32, Issue 5, 2011, Pages 1377-1386

  Shamay, Yosi ^a   Adar, Lily ^a   Ashkenasy, Gonen ^a   David, Ayelet ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Caged peptides; Cell penetrating peptides; Drug delivery; HPMA copolymers; Light activation

Indexed keywords

CAGED PEPTIDES; CANCER CELLS; CELL-PENETRATING PEPTIDE; CELL-PENETRATING PEPTIDES; CELLULAR UPTAKE; CYTOTOXIC ACTIVITIES; DRUG DELIVERY APPLICATIONS; DRUG-CONJUGATES; HPMA COPOLYMERS; IN-CELL; IN-VIVO; INTRACELLULAR DELIVERY; INTRACELLULAR DRUG DELIVERY; LIGHT ACTIVATION; LIGHT ILLUMINATION; NANO PARTICULATES; NONSPECIFIC ADSORPTION; PENETRATIN; POSITIVE CHARGES; POSITIVELY CHARGED; PROTECTING GROUP; SITE-SPECIFIC; TARGET CELLS; TUMOR TARGETING; UV LIGHT;

ADSORPTION; BEARINGS (STRUCTURAL); COPOLYMERIZATION; COPOLYMERS; CYTOLOGY; DRUG DELIVERY; PEPTIDES; POLYMERS;

CELLS;

CELL PENETRATING PEPTIDE; FLUORESCEIN ISOTHIOCYANATE; LEVULINIC ACID; LYSYLLEUCYLALANYLLYSYLLEUCYLALANYLLYSINE; PENETRATIN; POLYMER; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; DRUG DELIVERY SYSTEMS; HUMANS; LIGHT; METHACRYLATES; POLYMERS;

EID: 78649737496     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.10.029     Document Type: Article

References (46)

1. Torchilin V.P. Passive and active drug targeting: drug delivery to tumors as an example. Handb Exp Pharmacol 2010, 197:3-53.
2. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006, 6:688-701.
3. Kopecek J., Kopeckova P., Minko T., Lu Z. HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur J Pharm Biopharm 2000, 50:61-81.
4. Segal E., Satchi-Fainaro R. Design and development of polymer conjugates as anti-angiogenic agents. Adv Drug Deliv Rev 2009, 61:1159-1176.
5. Miller K., Erez R., Segal E., Shabat D., Satchi-Fainaro R. Targeting bone metastases with a bispecific anticancer and antiangiogenic polymer-alendronate-taxane conjugate. Angew Chem Int Ed Engl 2009, 48:2949-2954.
6. Shamay Y., Paulin D., Ashkenasy G., David A. Multivalent display of quinic acid based ligands for targeting E-selectin expressing cells. J Med Chem 2009, 52:5906-5915.
7. Shamay Y., Paulin D., Ashkenasy G., David A. E-selectin binding peptide-polymer-drug conjugates and their selective cytotoxicity against vascular endothelial cells. Biomaterials 2009, 30:6460-6468.
8. Allen T.M. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002, 2:750-763.
9. Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 46:6387-6392.
10. Schwarze S.R., Dowdy S.F. In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 2000, 21:45-48.
11. Lindgren M., Hallbrink M., Prochiantz A., Langel U. Cell-penetrating peptides. Trends Pharmacol Sci 2000, 21:99-103.
12. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572.
13. Michl J., Scharf B., Schmidt A., Huynh C., Hannan R., von Gizycki H., et al. PNC-28, a p53-derived peptide that is cytotoxic to cancer cells, blocks pancreatic cancer cell growth in vivo. Int J Cancer 2006, 119:1577-1585.
14. Jiang T., Olson E.S., Nguyen Q.T., Roy M., Jennings P.A., Tsien R.Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci U S A 2004, 101:17867-17872.
15. Olson E.S., Aguilera T.A., Jiang T., Ellies L.G., Nguyen Q.T., Wong E.H., et al. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol 2009, 1:382-393.
16. Nguyen Q.T., Olson E.S., Aguilera T.A., Jiang T., Scadeng M., Ellies L.G., et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc Natl Acad Sci U S A 2010, 107:4317-4322.
17. Sethuraman V.A., Bae Y.H. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J Control Release 2007, 118:216-224.
18. Kale A.A., Torchilin V.P. Design, synthesis, and characterization of pH-sensitive PEG-PE conjugates for stimuli-sensitive pharmaceutical nanocarriers: the effect of substitutes at the hydrazone linkage on the ph stability of PEG-PE conjugates. Bioconjug Chem 2007, 18:363-370.
19. Kratz F., Abu Ajaj K., Warnecke A. Anticancer carrier-linked prodrugs in clinical trials. Expert Opin Investig Drugs 2007, 16:1037-1058.
20. Forman J., Dietrich M., Monroe W.T. Photobiological and thermal effects of photoactivating UVA light doses on cell cultures. Photochem Photobiol Sci 2007, 6:649-658.
21. Rossi F.M., Margulis M., Tang C.M., Kao J.P. N-Nmoc-l-glutamate, a new caged glutamate with high chemical stability and low pre-photolysis activity. J Biol Chem 1997, 272:32933-32939.
22. Dadon Z., Samiappan M., Safranchik E.Y., Ashkenasy G. Light-induced peptide replication controls logic operations in small networks. Chem Eur J 2010, 16:12096-12099.
23. Shirakawa I., Chaen S., Bagshaw C.R., Sugi H. Measurement of nucleotide exchange rate constants in single rabbit soleus myofibrils during shortening and lengthening using a fluorescent ATP analog. Biophys J 2000, 78:918-926.
24. Hiraoka T., Hamachi I. Caged RNase: photoactivation of the enzyme from perfect off-state by site-specific incorporation of 2-nitrobenzyl moiety. Bioorg Med Chem Lett 2003, 13:13-15.
25. Cruz J.C., Thomas M., Wong E., Ohgami N., Sugii S., Curphey T., et al. Synthesis and biochemical properties of a new photoactivatable cholesterol analog 7,7-azocholestanol and its linoleate ester in Chinese hamster ovary cell lines. J Lipid Res 2002, 43:1341-1347.
26. Makings L.R., Tsien R.Y. Caged nitric oxide. Stable organic molecules from which nitric oxide can be photoreleased. J Biol Chem 1994, 269:6282-6285.
27. Srinivas O., Mitra N., Surolia A., Jayaraman N. Photoswitchable cluster glycosides as tools to probe carbohydrate-protein interactions: synthesis and lectin-binding studies of azobenzene containing multivalent sugar ligands. Glycobiology 2005, 15:861-873.
28. Goedhart J., Gadella T.W. Photolysis of caged phosphatidic acid induces flagellar excision in Chlamydomonas. Biochemistry 2004, 43:4263-4271.
29. Agasti S.S., Chompoosor A., You C.C., Ghosh P., Kim C.K., Rotello V.M. Photoregulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc 2009, 131:5728-5729.
30. Choi S.K., Thomas T., Li M.H., Kotlyar A., Desai A., Baker J.R. Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate. Chem Commun 2010, 46:2632-2634.
31. Dvir T, Banghart MR, Timko BP, Langer R, Kohane DS. Photo-targeted nanoparticles. Nano Lett;10:250-254.
32. Rothman D.M., Shults M.D., Imperiali B. Chemical approaches for investigating phosphorylation in signal transduction networks. Trends Cell Biol 2005, 15:502-510.
33. Mayer G., Heckel A. Biologically active molecules with a "Light switch" Angew Chem Intl Ed 2006, 45:4900-4921.
34. Lee H.-M., Larson D.R., Lawrence D.S. Illuminating the chemistry of life: design, synthesis, and applications of "caged" and related photoresponsive compounds. ACS Chem Biol 2009, 4:409-427.
35. Fischer P.M., Zhelev N.Z., Wang S., Melville J.E., Fahraeus R., Lane D.P. Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J Pept Res 2000, 55:163-172.
36. Javadpour M.M., Juban M.M., Lo W.C., Bishop S.M., Alberty J.B., Cowell S.M., et al. De novo antimicrobial peptides with low mammalian cell toxicity. J Med Chem 1996, 39:3107-3113.
37. Etrych T., Jelinkova M., Rihova B., Ulbrich K. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. J Control Release 2001, 73:89-102.
38. Drobnk J., Kopecek J., Labsky J., Rejmanova P., Exner J., Saudek V., et al. Enzymatic cleavage of side chains of synthetic water-soluble polymers. Makromol Chem 1976, 177:2833-2848.
39. Rihova B., Etrych T., Pechar M., Jelinkova M., Stastny M., Hovorka O., et al. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes. J Control Release 2001, 74:225-232.
40. Omelyanenko V., Kopeckova P., Gentry C., Kopecek J. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate. J Control Release 1998, 53:25-37.
41. Kopecek J.B.H. Poly[N-(2-hydroxypropyl)methacrylamide] I. Radical polymerization and copolymerization. Eur Polym J 1973, 9:7-14.
42. Sarin V.K., Kent S.B., Tam J.P., Merrifield R.B. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem 1981, 117:147-157.
43. Law B., Quinti L., Choi Y., Weissleder R., Tung C.H. A mitochondrial targeted fusion peptide exhibits remarkable cytotoxicity. Mol Cancer Ther 2006, 5:1944-1949.
44. Mai J.C., Mi Z., Kim S.H., Ng B., Robbins P.D. A proapoptotic peptide for the treatment of solid tumors. Cancer Res 2001, 61:7709-7712.
45. Gagey N., Neveu P., Jullien L. Two-photon uncaging with the efficient 3,5-dibromo-2,4-dihydroxycinnamic caging group. Angew Chem Int Ed Engl 2007, 46:2467-2469.
46. Pawlicki M., Collins H.A., Denning R.G., Anderson H.L. Two-photon absorption and the design of two-photon dyes. Angew Chem Int Ed Engl 2009, 48:3244-3266.